Haemonetics 2nd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website

BRAINTREE, Mass., Nov. 7, 2016

The Company is posting this press release and additional commentary entitled Comments on 2^nd Quarter and First Half Fiscal 2017 Results to its Investor Relations website. 

Direct link to Earnings Release FY17 Q2: 
 http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzU2MzQzfENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636132771088636200

Direct link to Comments on 2^nd Quarter and 1^st Half Fiscal 2017 Results: 
 http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzU2MzQ0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636132771875970279

As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on November 7, 2016. A live webcast of the call can be accessed on Haemonetics' investor relations website.

Direct link to Conference Call Webcast: http://edge.media-server.com/m/p/wcn22ipf/lan/en

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.